Ureaplasma loridis

From WikiMD's WELLNESSPEDIA

Ureaplasma loridis is a species of bacteria in the genus Ureaplasma, which is part of the family Mycoplasmataceae. This species is known to inhabit the urogenital tract of humans and can be associated with various diseases.

Taxonomy[edit]

The genus Ureaplasma is divided into two groups based on the serological specificity of the organisms. The first group includes Ureaplasma parvum and Ureaplasma urealyticum, while the second group includes Ureaplasma loridis and other species. The genus Ureaplasma is part of the family Mycoplasmataceae, which is a large family of bacteria that lack a cell wall and are therefore resistant to many common antibiotics.

Morphology[edit]

Like all Ureaplasma species, Ureaplasma loridis is a small, pleomorphic bacterium that lacks a cell wall. This makes it resistant to many common antibiotics that target cell wall synthesis. The bacteria are typically coccoid in shape and can form clusters or chains.

Pathogenicity[edit]

Ureaplasma loridis is known to inhabit the urogenital tract of humans. It can be associated with various diseases, including non-gonococcal urethritis, pelvic inflammatory disease, and infertility. However, the exact role of Ureaplasma loridis in these diseases is not fully understood and is the subject of ongoing research.

Treatment[edit]

Treatment of infections caused by Ureaplasma loridis typically involves antibiotics that are effective against cell wall-deficient bacteria, such as tetracyclines or macrolides. However, resistance to these antibiotics has been reported, making treatment more challenging.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.